ANVS: Annovis Bio, Inc. Stock

by  •  • Comments Off on ANVS: Annovis Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 149.75
Enterprise Value ($M) 144.00
Book Value ($M) -7.75
Book Value / Share -0.70
Price / Book -19.32
NCAV ($M) -7.75
NCAV / Share -0.70
Price / NCAV -19.32

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.20
Return on Equity (ROE) -2.79

Liquidity (mrq)
Quick Ratio 2.39
Current Ratio 2.39

Balance Sheet (mrq) ($M)
Current Assets 10.21
Assets 10.21
Liabilities 17.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -45.04
Net Income -56.20
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -39.97
Cash from Investing 0.00
Cash from Financing 17.34

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-28 13G/A Hirschman Orin 4.58 -18.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 343,311 1,039,977 33.01
2024-04-25 99,895 324,983 30.74
2024-04-24 126,593 490,353 25.82
2024-04-23 63,159 226,539 27.88
2024-04-22 90,088 321,068 28.06

(click for more detail)

Similar Companies
ABT – Abbott Laboratories ADCT – ADC Therapeutics SA
ANRO – Alto Neuroscience, Inc. BHC – Bausch Health Companies Inc.
BHVN – Biohaven Ltd.


Financial data and stock pages provided by
Fintel.io